Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Health Aff (Millwood) ; 42(3): 416-423, 2023 03.
Article in English | MEDLINE | ID: covidwho-2257358

ABSTRACT

During the COVID-19 pandemic in Mississippi in 2020 and 2021, nonurgent elective procedures requiring hospitalization were halted three times to preserve the state's hospital resources. To evaluate the change in hospital intensive care unit (ICU) capacity after the implementation of this policy, we analyzed Mississippi's hospital discharge data. We compared daily mean ICU admissions and census for nonurgent elective procedures between three intervention periods and baseline periods corresponding to Mississippi State Department of Health executive orders. We further evaluated the observed and predicted trends, using interrupted time series analyses. Overall, the executive orders reduced the mean number of ICU admissions for elective procedures from 13.4 patients to 9.8 patients daily (a 26.9 percent decline). This policy also decreased the mean ICU census for nonurgent elective procedures from 68.0 patients to 56.6 patients daily (a 16.8 percent decline). The state managed to free, on average, eleven ICU beds daily. Postponing nonurgent elective procedures in Mississippi was a successful strategy that resulted in a decline in ICU bed use for nonurgent elective surgeries during times of unprecedented stress on the health care system.


Subject(s)
COVID-19 , Pandemics , Humans , Mississippi/epidemiology , Critical Care , Intensive Care Units
2.
Pediatr Infect Dis J ; 41(9): 736-741, 2022 09 01.
Article in English | MEDLINE | ID: covidwho-1891097

ABSTRACT

BACKGROUND: Racial disparities in SARS-CoV-2 infection, hospitalization, and multisystem inflammatory syndrome in children (MIS-C) have been reported. However, these reports have been based on incomplete data relying on passive reporting, unknown catchment populations, and unknown infection prevalence. We aimed to characterize population-based incidence of MIS-C and COVID-19 hospitalizations among non-Hispanic Black and White children using active surveillance based on seroprevalence-based cumulative incidence of pediatric SARS-CoV-2 infection in a defined catchment 16-county area of Mississippi. METHODS: Active, population-based surveillance for MIS-C and acute COVID-19 hospitalizations meeting clinical and laboratory criteria was conducted by adjudicating clinicians at the major pediatric referral hospital for Mississippi, University of Mississippi Medical Center, from March 2020, to February 2021. Race-stratified SARS-CoV-2 seroprevalence was estimated using convenience samples from persons <18 years to calculate cumulative SARS-CoV-2 infections in the population. RESULTS: Thirty-eight MIS-C cases and 74 pediatric acute COVID-19 hospitalizations were identified. Cumulative incidence of MIS-C was 4.7 times higher among Black compared with White children (40.7 versus 8.3 cases per 100,000 SARS-CoV-2 infections). Cumulative incidence of COVID-19 hospitalization was 62.3 among Black and 33.1 among White children per 100,000 SARS-CoV-2 infections. CONCLUSIONS: From the same catchment area, active surveillance, and cumulative incidence of infection estimated by seroprevalence, we show strikingly higher incidence of SARS-CoV-2-hospitalization and MIS-C in non-Hispanic Black children compared with White children before COVID-19 vaccination introduction in children. These disparities in SARS-CoV-2 manifestations cannot be accounted for by differences in exposure or testing. Targeted vaccine interventions will lessen disparities observed with SARS-CoV-2 manifestations in children.


Subject(s)
COVID-19 , SARS-CoV-2 , COVID-19/complications , COVID-19/epidemiology , COVID-19 Vaccines , Child , Hospitalization , Humans , Mississippi/epidemiology , Seroepidemiologic Studies , Systemic Inflammatory Response Syndrome , Watchful Waiting
3.
MMWR Morb Mortal Wkly Rep ; 70(47): 1646-1648, 2021 Nov 26.
Article in English | MEDLINE | ID: covidwho-1534935

ABSTRACT

Pregnant and recently pregnant women are at increased risk for severe illness and death from COVID-19 compared with women who are not pregnant or were not recently pregnant (1,2). CDC recommends COVID-19 vaccination for women who are pregnant, recently pregnant, trying to become pregnant, or might become pregnant in the future.*,† This report describes 15 COVID-19-associated deaths after infection with SARS-CoV-2 (the virus that causes COVID-19) during pregnancy in Mississippi during March 1, 2020-October 6, 2021.


Subject(s)
COVID-19/mortality , Pregnancy Complications, Infectious/epidemiology , Adult , COVID-19 Vaccines/administration & dosage , Centers for Disease Control and Prevention, U.S. , Female , Humans , Mississippi/epidemiology , Practice Guidelines as Topic , Pregnancy , Risk Assessment , United States , Young Adult
4.
Pediatrics ; 148(5)2021 11.
Article in English | MEDLINE | ID: covidwho-1357451

ABSTRACT

OBJECTIVES: To describe the demographics, clinical characteristics, and hospital course among persons <21 years of age with a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated death. METHODS: We conducted a retrospective case series of suspected SARS-CoV-2-associated deaths in the United States in persons <21 years of age during February 12 to July 31, 2020. All states and territories were invited to participate. We abstracted demographic and clinical data, including laboratory and treatment details, from medical records. RESULTS: We included 112 SARS-CoV-2-associated deaths from 25 participating jurisdictions. The median age was 17 years (IQR 8.5-19 years). Most decedents were male (71, 63%), 31 (28%) were Black (non-Hispanic) persons, and 52 (46%) were Hispanic persons. Ninety-six decedents (86%) had at least 1 underlying condition; obesity (42%), asthma (29%), and developmental disorders (22%) were most commonly documented. Among 69 hospitalized decedents, common complications included mechanical ventilation (75%) and acute respiratory failure (82%). The sixteen (14%) decedents who met multisystem inflammatory syndrome in children (MIS-C) criteria were similar in age, sex, and race and/or ethnicity to decedents without MIS-C; 11 of 16 (69%) had at least 1 underlying condition. CONCLUSIONS: SARS-CoV-2-associated deaths among persons <21 years of age occurred predominantly among Black (non-Hispanic) and Hispanic persons, male patients, and older adolescents. The most commonly reported underlying conditions were obesity, asthma, and developmental disorders. Decedents with coronavirus disease 2019 were more likely than those with MIS-C to have underlying medical conditions.


Subject(s)
COVID-19/complications , Systemic Inflammatory Response Syndrome/mortality , Adolescent , COVID-19/diagnosis , COVID-19/mortality , Child , Child, Preschool , Female , Humans , Infant , Male , Retrospective Studies , Systemic Inflammatory Response Syndrome/complications , Systemic Inflammatory Response Syndrome/diagnosis , United States/epidemiology
6.
MMWR Morb Mortal Wkly Rep ; 69(50): 1925-1929, 2020 Dec 18.
Article in English | MEDLINE | ID: covidwho-983904

ABSTRACT

As of December 14, 2020, children and adolescents aged <18 years have accounted for 10.2% of coronavirus disease 2019 (COVID-19) cases reported in the United States.* Mitigation strategies to prevent infection with SARS-CoV-2, the virus that causes COVID-19, among persons of all ages, are important for pandemic control. Characterization of risk factors for SARS-CoV-2 infection among children and adolescents can inform efforts by parents, school and program administrators, and public health officials to reduce SARS-CoV-2 transmission. To assess school, community, and close contact exposures associated with pediatric COVID-19, a case-control study was conducted to compare exposures reported by parents or guardians of children and adolescents aged <18 years with SARS-CoV-2 infection confirmed by reverse transcription-polymerase chain reaction (RT-PCR) testing (case-patients) with exposures reported among those who received negative SARS-CoV-2 RT-PCR test results (control participants). Among 397 children and adolescents investigated, in-person school or child care attendance ≤14 days before the SARS-CoV-2 test was reported for 62% of case-patients and 68% of control participants and was not associated with a positive SARS-CoV-2 test result (adjusted odds ratio [aOR] = 0.8, 95% confidence interval [CI] = 0.5-1.3). Among 236 children aged ≥2 years who attended child care or school during the 2 weeks before SARS-CoV-2 testing, parents of 64% of case-patients and 76% of control participants reported that their child and all staff members wore masks inside the facility (aOR = 0.4, 95% CI = 0.2-0.8). In the 2 weeks preceding SARS-CoV-2 testing, case-patients were more likely to have had close contact with a person with known COVID-19 (aOR = 3.2, 95% CI = 2.0-5.0), have attended gatherings† with persons outside their household, including social functions (aOR = 2.4, 95% CI = 1.1-5.5) or activities with other children (aOR = 3.3, 95% CI = 1.3-8.4), or have had visitors in the home (aOR = 1.9, 95% CI = 1.2-2.9) than were control participants. Close contacts with persons with COVID-19 and gatherings contribute to SARS-CoV-2 infections in children and adolescents. Consistent use of masks, social distancing, isolation of infected persons, and quarantine of those who are exposed to the virus continue to be important to prevent COVID-19 spread.


Subject(s)
Ambulatory Care Facilities/statistics & numerical data , COVID-19 Testing/statistics & numerical data , COVID-19/diagnosis , Emergency Service, Hospital/statistics & numerical data , Adolescent , COVID-19/epidemiology , COVID-19/transmission , Child , Child, Preschool , Female , Humans , Male , Mississippi/epidemiology , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL